Detalles de la búsqueda
1.
Virus-induced senescence is a driver and therapeutic target in COVID-19.
Nature
; 599(7884): 283-289, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34517409
2.
Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.
Eur Respir J
; 63(4)2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38423624
3.
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases.
Curr Opin Pulm Med
; 30(2): 156-166, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37902135
4.
Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease.
Semin Respir Crit Care Med
; 45(1): 102-113, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38196060
5.
Treatment of MDR, pre-XDR, XDR and rifampicin-resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment to the 2022 consensus-based guideline: Tuberculosis in adulthood by the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP) dated 19.09.2023.
Respiration
; 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38810608
6.
[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)]. / Therapie bei MDR-, prä-XDR-, XDR-Tuberkulose und Rifampicin-Resistenz oder bei Medikamentenunverträglichkeit gegenüber mindestens Rifampicin.
Pneumologie
; 78(1): 35-46, 2024 Jan.
Artículo
en Alemán
| MEDLINE | ID: mdl-37931778
7.
The Austrian landscape of diagnostic capacity and access to treatment for invasive fungal infections.
Mycoses
; 66(12): 1056-1063, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592370
8.
Tuberculosis incidence in foreign-born people residing in European countries in 2020.
Euro Surveill
; 28(42)2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855907
9.
Characterization of Treatment Response Outcomes in Chronic Pulmonary Aspergillosis: CPAnet Definitions Versus the Existing Criteria.
Mycopathologia
; 188(5): 721-730, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37291204
10.
[National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic DMARDS (disease modifying antirheumatic drugs)]. / Consensus Statement der Österreichischen Gesellschaften für Rheumatologie und Rehabilitation, Pneumologie, Infektiologie, Dermatologie und Gastroenterologie zum Umgang mit latenter Tuberkulose bei Therapien mit biologischen oder "targeted synthetic" DMARDs ("disease modifying antirheumatic drugs").
Z Rheumatol
; 82(2): 163-174, 2023 Mar.
Artículo
en Alemán
| MEDLINE | ID: mdl-36342525
11.
qSOFA score poorly predicts critical progression in COVID-19 patients.
Wien Med Wochenschr
; 172(9-10): 211-219, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34185216
12.
Rare manifestation of a large stenosing gastrointestinal tumor caused by Mycobacterium tuberculosis in a previously healthy man from Austria.
Wien Med Wochenschr
; 172(11-12): 268-273, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34613520
13.
[Tuberculosis in adulthood - The Sk2-Guideline of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the diagnosis and treatment of adult tuberculosis patients]. / Tuberkulose im Erwachsenenalter.
Pneumologie
; 76(11): 727-819, 2022 Nov.
Artículo
en Alemán
| MEDLINE | ID: mdl-36384164
14.
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model.
Eur Respir J
; 58(3)2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33574078
15.
Nontuberculous Mycobacterial Pulmonary Disease from Mycobacterium hassiacum, Austria.
Emerg Infect Dis
; 26(11): 2776-2778, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079051
16.
Chronic pulmonary aspergillosis update: A year in review.
Med Mycol
; 57(Supplement_2): S104-S109, 2019 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30816975
17.
Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings.
Emerg Infect Dis
; 24(8)2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30016256
18.
A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention.
J Antimicrob Chemother
; 73(2): 280-286, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29126309
19.
Pulmonary Diseases in Refugees and Migrants in Europe.
Respiration
; 95(4): 273-286, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29414830
20.
Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
Respiration
; 96(1): 52-65, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29635251